A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).
Susanna K TanDeborah CebrikDavid PlotnikMaria L AgostiniKeith BoundyChristy M HebnerWendy W YehPhillip S PangJaynier MoyaCharles FogartyManuchehr DaraniFrederick G HaydenPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
VIR-2482 1200 mg IM was well tolerated but did not significantly prevent protocol-defined ILI. Secondary endpoint analyses suggest this dose may have reduced influenza A illness.